share_log
Breakings ·  Sep 13 22:00
Prelude Therapeutics Inc - PRT3789 Generally Well-Tolerated With No Dose-Limiting Toxicities
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment